The second element of the model relies on the role of ATF3 activation on blocking the MDM2 degradation of p53 [84] and preventing the translocation of p53 to the cytoplasm, thus contributing to its tumor-suppressor activity [85]. Here, MDM2 is linked to neoplasm.